Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial

Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination (DCVax-L) in glioblastoma: breakthrough or fata morgana?

Derivation and external validation of dendritic cell-related gene signatures for predicting prognosis and immunotherapy efficacy in bladder urothelial carcinoma

Dendritic cell vaccines improve the glioma microenvironment: Influence, challenges, and future directions

Immunotherapy for the treatment of pediatric brain tumors: a narrative review

Oncolytic Viruses for the Treatment of Bladder Cancer: Advances, Challenges, and Prospects

Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy

Commentary on „Systematic review about complementary medical hyperthermia in oncology“ by Liebl et al

Immunogenic Cell Death Role in Urothelial Cancer Therapy